Table 1.

Survey Questions

Which of the following do you consider your primary training to fall under?
○ Lab-based research	○ Clinical research	○ Clinical	○ Other (specify)
Which of the following best describes your position or rank at the time of the study? (select one)
○ Student (e.g., medical student or doctoral student)			○ Mid-level research scientist (e.g., associate professor)
○ Trainee (e.g., medical resident or fellow, postdoctoral fellow)			○ Senior-level research scientist (e.g., full professor)
○ Junior-level research scientist (e.g., instructor, adjunct professor, assistant professor)			○ Other (specify)
How was this study funded? (mark all that apply)
○ Governmental agency (e.g., National Institutes of Health, Medical Research Council, European Union)			○ For-profit commercial or private organization	○ Intramural funding from your institution
			○ Not-for-profit organization or foundation	○ Other (specify)
How would you describe the results of this study?
○ Positive	○ Negative	○ Equivocal
Is this biomaterial still being researched as a potential nerve scaffold in clinical use?
○ Yes	○ No	○ I do not know
Is this biomaterial currently available as a nerve scaffold in clinical use?
○ Yes	○ No	○ I do not know
Please select any factor that you feel is preventing or has prevented this biomaterial from moving forward to clinical use. (mark all that apply)
○ Further testing demonstrated it would not be useful			○ No access to a large animal facility for additional testing
○ Insufficient financial resources			○ No access to an appropriate patient population
○ Lack of expertise in regulatory affairs			○ My research program is not involved in translating basic research to clinical use
○ Lack of appropriate clinical collaborators			○ My research changed emphasis or direction
○ Lack of a commercial partner			○ Other reason
○ Expectation that a commercial entity or company would translate the biomaterial to a clinical product
Of the factors you selected in question 6 above, please select the single most important factor you feel is preventing or has prevented this material from moving forward to clinical use. (select one)
○ Further testing demonstrated it would not be useful			○ No access to a large animal facility for additional testing
○ Insufficient financial resources			○ No access to an appropriate patient population
○ Lack of expertise in regulatory affairs			○ My research program is not involved in translating basic research to clinical use
○ Lack of appropriate clinical collaborators			○ My research changed emphasis or direction
○ Lack of a commercial partner			○ Other reason
○ Expectation that a commercial entity or company would translate the biomaterial to a clinical product
Please provide any other information that would be helpful in understanding the barriers preventing this biomaterial from moving forward to clinical use:
(free text)
Thank you for your participation. Would you like to be listed in the acknowledgments of our manuscript summarizing the results of this survey?
○ Yes	○ No
Please type your name as you would like it to appear in the acknowledgment
(free text)